ClinicalTrials.gg
Drug

Tegafur clinical trials

studies test it
189
open now
27
in phase 3
30
first study started
2001

Counted the way a researcher would: Tegafur with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Tegafur is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Tegafur studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
14 Mar 2011 · Teysuno · EMEA/H/C/001242 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tegafur
4

In one entry with another drug

Given together, or one or the other

S-1
47
TS-1
14
SOX
6
S1
5
S-1/Cisplatin
4
Nab-paclitaxel and S-1
4
S-1 and Oxaliplatin
3
TS-1® with Cisplatin
3

Studies by the year they started

189 studies that test it; most in 2013 (13)

Studies that test Tegafur, by start year
YearStudies
20011
20021
20043
20057
200612
200711
200811
200910
201010
20119
20129
201313
20147
201511
201613
20179
20185
20199
20206
20214
20225
20235
20245
202510
20263

Who runs them

Industry 25 · Other 164

Chinese Academy of Medical Sciences (11) · Fudan University (10) · Taiho Pharmaceutical Co., Ltd. (10) · Taiho Oncology, Inc. (9) · National Cancer Center, Korea (9) · Kansai Hepatobiliary Oncology Group (6) · Yonsei University (5) · Samsung Medical Center (5)

Often tested with

Tested in the same studies.

Gimeracil (183) · Oxonic Acid (181) · Oxaliplatin (49) · Paclitaxel (27) · Gemcitabine (20) · Albumin-Bound Paclitaxel (19) · Cisplatin (17) · Leucovorin (15)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 5 phase 3 studies under way

Tegafur is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 10

Studies that test Tegafur.

Studies

Open first, then newest update. How each study uses Tegafur is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 189

See all 189 studies that test Tegafur →

Given beside what is tested · 179 — Tegafur is usual care or a partner of the new treatment

Showing 20 of 179.

As the comparator · 20 — what is tested is compared with Tegafur

Codes

What other systems call Tegafur · ClinicalTrials.gg INT007527

  • MeSH (NLM) D005641TegafurConfirmed NLM, Wikidata
  • UNII (FDA) 1548R74NSZTEGAFURConfirmed FDA, NLM, Wikidata
  • RxNorm 4582Confirmed FDA, Wikidata
  • Wikidata Q413370(RS)-tegafurConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C513TegafurOne source FDA
  • DrugBank DB09256One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.